This inventor holds 1 USPTO granted patent and 7 published patent applications and 1 EPO patent. Top assignee: University Health Network. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Chang-Qi Zhu: Innovator in Lung Cancer Prognostics
Introduction: Chang-Qi Zhu is a prominent inventor based in Thornhill, CA. He has made significant contributions to the field of oncology, particularly in the area of lung cancer treatment. His innovative work focuses on improving patient outcomes through advanced genetic analysis.
Latest Patents: Chang-Qi Zhu holds a patent for a "Prognostic and predictive gene signature for non-small cell lung cancer and adjuvant chemotherapy." This application provides methods for prognosing and classifying lung cancer patients into poor survival groups or good survival groups. It also determines the benefit of adjuvant chemotherapy through a multigene signature. The application includes kits and computer products designed for use in these methods.
Career Highlights: Zhu is affiliated with the University Health Network, where he continues to advance research in cancer treatment. His work has the potential to significantly impact the way lung cancer is diagnosed and treated, offering hope to many patients.
Collaborations: He has collaborated with notable colleagues, including Keyue Ding and Ming-Sound Tsao, to further enhance the research and development of cancer prognostics.
Conclusion: Chang-Qi Zhu's innovative contributions to lung cancer research exemplify the importance of genetic analysis in improving patient care. His work not only advances scientific understanding but also offers practical solutions for better treatment outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile